A client is diagnosed with an st segment elevation myocardial infarction (stemi) and is receiving a tissue plasminogen activator, alteplase. monitoring for signs of bleeding is the priority nursing intervention.
<h3>Tissue Plasminogen activator:</h3>
It is a thrombolytic. symptomatic and systemic hemorrhage is a complication of any type of thrombolytic medication.
Tissue Plasminogen activator is an enzyme which is useful to treat diseases which includes heart attack, strokes and blood clots ,etc.
It is one type of glyco-protien which produced mainly a vascular endothelial cells.
The side effects of tissue Plasminogen activator includes headache, bleeding from the wound, paralysis, difficulties in breathing and swallowing, etc.
Alteplase is a fibrinolytic agent . it is also referred to as tissue plasminogen activator (tPA). Alteplase converts plasminogen to the proteolytic enzyme plasmin, which lyses fibrin as well as fibrinogen.
<h3>What is blood clots? </h3>
Blood clots are gel-like thick collections of blood that form in your veins or arteries when blood changes from liquid to partially solid.
A blood clot is also called a thrombus.
Learn more about blood clots here:
brainly.com/question/8204597
#SPJ4
